JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,106,000 | +1201.2% | 178,427 | +605.6% | 0.00% | – |
| Q4 2018 | $85,000 | -74.1% | 25,287 | -50.0% | 0.00% | – |
| Q3 2018 | $328,000 | +54.0% | 50,574 | +81.6% | 0.00% | – |
| Q2 2018 | $213,000 | -66.9% | 27,842 | -3.2% | 0.00% | – |
| Q1 2018 | $643,000 | +75.2% | 28,758 | 0.0% | 0.00% | – |
| Q4 2017 | $367,000 | -44.1% | 28,758 | -31.8% | 0.00% | – |
| Q3 2017 | $657,000 | -27.4% | 42,192 | -34.6% | 0.00% | -100.0% |
| Q2 2017 | $905,000 | +295.2% | 64,532 | +519.7% | 0.00% | – |
| Q1 2017 | $229,000 | – | 10,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |